An electro-amalgamation approach to isolate no-carrier-added 177Lu from neutron irradiated Yb for biomedical applicationsRubel Chakravarty, Meera Venkatesh, Tapas Das et al.|Nuclear Medicine and Biology|2010Cited by 68
Formulation and clinical translation of [ <sup>177</sup> Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancerMohini Guleria, Tapas Das, Rohit Sharma et al.|RSC Medicinal Chemistry|2020Cited by 33
Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future DirectionsAshutosh Dash, F. F. Knapp, Tapas Das|Current Medicinal Chemistry|2019Cited by 23
Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of <sup>68</sup> Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse ModelMohini Guleria, Ashutosh Dash, Tapas Das et al.|Cancer Biotherapy and Radiopharmaceuticals|2018Cited by 20
Synthesis and Biological Evaluation of <sup>90</sup> Y-Labeled Porphyrin-DOTA Conjugate: A Potential Molecule for Targeted Tumor TherapySweety Mittal, M.R.A. Pillai, Mohini Bhadwal et al.|Cancer Biotherapy and Radiopharmaceuticals|2013Cited by 18